Affiliations
AffiliationItem in Clipboard
Predictors of colorectal cancer testing using the California Health Inventory SurveyAlexandra Modiri et al. World J Gastroenterol. 2013.
. 2013 Feb 28;19(8):1247-55. doi: 10.3748/wjg.v19.i8.1247. AffiliationItem in Clipboard
AbstractAim: To identify key variables associated with colon cancer testing using the 2009 California Health Inventory Survey (CHIS).
Methods: The CHIS has been conducted biennially since 2001 using a two-stage, geographically stratified random-digit-dial sample design to produce a representative sample of the entire State. For this study we used survey data from 2001-2009 inclusive. We restricted our analysis to White, Black, and Hispanic/Latinos aged 50-80 years. Weighted data was used to calculate the proportion of participants who underwent some form of colon cancer testing (colonoscopy, flexible sigmoidoscopy or fecal occult blood testing) within the previous 5 years stratified by race/ethnicity. For inferential analysis, boot-strapping with replacement was performed on the weighted sample to attain variance estimates at the 95%CI. For mean differences among categories we used t-tests and for comparisons of categorical data we used Pearson's χ(2). Binary logistic regression was used to identify independent variables associated with undergoing some form of testing. Trend analysis was performed to determine rates of testing over the study period stratified by race.
Results: The CHIS database for 2009 had 30 857 unique respondents corresponding to a weighted sample size of 10.6 million Californians. Overall, 63.0% (63.0-63.1) underwent a colon cancer test within the previous 5 years; with 70.5% (70.5%-70.6%) of this subset having undergone colonoscopy. That is 44.5% (44.4%-44.5%) of all individuals 50-80 underwent colonoscopy. By multivariable regression, those tested were more likely to be male (OR = 1.06; 95%CI: 1.06-1.06), Black (OR = 1.30; 95%CI: 1.30-1.31), have a family member with colon cancer (OR = 1.71; 95%CI: 1.70-1.72), and have health insurance (OR = 2.71; 95%CI: 2.70-2.72). Progressive levels above the poverty line were also associated with receiving a test (100%-199%: 1.21; 1.20-1.21), (200%-299%:1.41; 1.40-1.42), (> 300:1.69; 1.68-1.70). The strongest variable was physician recommendation (OR = 3.90; 95%CI: 3.88-3.91). For the Hispanic/Latino group, additional variables associated with testing were success of physician-patient communication (OR = 2.44; 95%CI: 2.40-2.48) and naturalized citizenship status (OR = 1.91; 95%CI: 1.89-1.93). Trend analysis demonstrated increased colon cancer testing for all racial/ethnic subgroups from 2001-2009 although the rate remained considerably lower for the Hispanic/Latino subgroup.
Conclusion: Using CHIS we identified California citizens most likely to undergo colon cancer testing. The strongest variable associated with testing for all groups was physician recommendation.
Keywords: California Health Inventory Survey; Colon cancer testing; Colonoscopy; Hispanic.
FiguresFigure 1
Proportion of individuals aged 50-80…
Figure 1
Proportion of individuals aged 50-80 undergoing a colon cancer test in the previous…
Figure 1Proportion of individuals aged 50-80 undergoing a colon cancer test in the previous 5 years stratified by race/ethnicity.
Similar articlesJohnson-Kozlow M, Roussos S, Rovniak L, Hovell M. Johnson-Kozlow M, et al. Ethn Dis. 2009 Summer;19(3):315-22. Ethn Dis. 2009. PMID: 19769015 Free PMC article.
Fenton JJ, Cai Y, Green P, Beckett LA, Franks P, Baldwin LM. Fenton JJ, et al. Am J Prev Med. 2008 Sep;35(3):194-202. doi: 10.1016/j.amepre.2008.05.029. Epub 2008 Jul 10. Am J Prev Med. 2008. PMID: 18619761
Etzioni DA, Ponce NA, Babey SH, Spencer BA, Brown ER, Ko CY, Chawla N, Breen N, Klabunde CN. Etzioni DA, et al. Cancer. 2004 Dec 1;101(11):2523-32. doi: 10.1002/cncr.20692. Cancer. 2004. PMID: 15505783
Warren Andersen S, Blot WJ, Lipworth L, Steinwandel M, Murff HJ, Zheng W. Warren Andersen S, et al. JAMA Netw Open. 2019 Dec 2;2(12):e1917995. doi: 10.1001/jamanetworkopen.2019.17995. JAMA Netw Open. 2019. PMID: 31860105 Free PMC article.
Dodou D, de Winter JC. Dodou D, et al. Eur J Cancer Care (Engl). 2015 May;24(3):286-98. doi: 10.1111/ecc.12204. Epub 2014 Apr 23. Eur J Cancer Care (Engl). 2015. PMID: 24754544 Review.
Wang KS, Liu X, Ategbole M, Xie X, Liu Y, Xu C, Xie C, Sha Z. Wang KS, et al. Asian Pac J Cancer Prev. 2017 Sep 27;18(9):2581-2589. doi: 10.22034/APJCP.2017.18.9.2581. Asian Pac J Cancer Prev. 2017. PMID: 28952708 Free PMC article.
Ojinnaka CO, Bolin JN, McClellan DA, Helduser JW, Nash P, Ory MG. Ojinnaka CO, et al. Prev Med Rep. 2015 Feb 24;2:158-63. doi: 10.1016/j.pmedr.2015.02.009. eCollection 2015. Prev Med Rep. 2015. PMID: 26844065 Free PMC article.
Almario CV, May FP, Ponce NA, Spiegel BM. Almario CV, et al. Clin Gastroenterol Hepatol. 2015 Aug;13(8):1487-95. doi: 10.1016/j.cgh.2015.02.038. Epub 2015 Feb 28. Clin Gastroenterol Hepatol. 2015. PMID: 25737445 Free PMC article.
Johnson Shen M, Elston Lafata J, D'Agostino TA, Bylund CL. Johnson Shen M, et al. J Health Commun. 2020;25(1):43-53. doi: 10.1080/10810730.2019.1697909. Epub 2019 Dec 4. J Health Commun. 2020. PMID: 31795843 Free PMC article.
May FP, Yano EM, Provenzale D, Neil Steers W, Washington DL. May FP, et al. Dig Dis Sci. 2017 Aug;62(8):1923-1932. doi: 10.1007/s10620-017-4607-x. Epub 2017 May 20. Dig Dis Sci. 2017. PMID: 28528373
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3